PRAX - Company ID 0001689548
The table below shows Praxis Precision Medicines, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | $0.00 | $0.00 | $0.00 | - | $302.00K |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $77.99M | $65.80M | $63.01M | $60.81M | - | $41.88M |
Praxis Precision Medicines, Inc. reported annual revenue of $0.00 for fiscal year 2025. That is down 100.0% from $8.55M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $27.87M |
| $12.56M |
| $13.06M |
| $13.92M |
| - |
| $15.26M |
| Operating income | -$105.86M | -$78.36M | -$76.07M | -$74.73M | - | -$56.84M |
| Income tax | - | - | - | - | - | - |
| Net income | -$92.56M | -$73.93M | -$71.13M | -$69.30M | -$58.68M | -$51.91M |
| EPS (diluted) | -$3.20 | -$3.36 | -$3.31 | -$3.29 | - | -$2.75 |